Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Submitted by
admin
on August 4, 2016 - 9:56am
Source:
Endpoints
News Tags:
Adaptimmune
T-cells
myxoid round cell liposarcoma
CAR-T
cancer immunotherapy
Headline:
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Do Not Allow Advertisers to Use My Personal information